Evidence map›Paper›PMID 37542049›Full record

ArticleNature communications2023

The AT-hook is an evolutionarily conserved auto-regulatory domain of SWI/SNF required for cell lineage priming.

Dhurjhoti Saha, Solomon Hailu, Arjan Hada, Junwoo Lee, Jie Luo, Jeff A Ranish, Yuan-Chi Lin, Kyle Feola, Jim Persinger, Abhinav Jain and 4 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Dhurjhoti SahaDepartment of Epigenetics and Molecular Carcinogenesis, Univ. of Texas MD Anderson Cancer Center, Houston, TX, 77230, USA.
Solomon HailuDepartment of Epigenetics and Molecular Carcinogenesis, Univ. of Texas MD Anderson Cancer Center, Houston, TX, 77230, USA.
Arjan HadaDepartment of Epigenetics and Molecular Carcinogenesis, Univ. of Texas MD Anderson Cancer Center, Houston, TX, 77230, USA.
Junwoo LeeDepartment of Epigenetics and Molecular Carcinogenesis, Univ. of Texas MD Anderson Cancer Center, Houston, TX, 77230, USA.ORCID http://orcid.org/0000-0001-5821-2274
Jie LuoInstitute for Systems Biology, Seattle, WA, 98109, USA.
Jeff A RanishInstitute for Systems Biology, Seattle, WA, 98109, USA.ORCID http://orcid.org/0000-0001-7181-0287
Yuan-Chi LinDepartment of Epigenetics and Molecular Carcinogenesis, Univ. of Texas MD Anderson Cancer Center, Houston, TX, 77230, USA.
Kyle FeolaDepartment of Epigenetics and Molecular Carcinogenesis, Univ. of Texas MD Anderson Cancer Center, Houston, TX, 77230, USA.
Jim PersingerDepartment of Epigenetics and Molecular Carcinogenesis, Univ. of Texas MD Anderson Cancer Center, Houston, TX, 77230, USA.
Abhinav JainDepartment of Epigenetics and Molecular Carcinogenesis, Univ. of Texas MD Anderson Cancer Center, Houston, TX, 77230, USA.ORCID http://orcid.org/0000-0003-3268-514X
Bin LiuDepartment of Epigenetics and Molecular Carcinogenesis, Univ. of Texas MD Anderson Cancer Center, Houston, TX, 77230, USA.
Yue LuDepartment of Epigenetics and Molecular Carcinogenesis, Univ. of Texas MD Anderson Cancer Center, Houston, TX, 77230, USA.
Payel SenLaboratory of Genetics and Genomics, National Institute on Aging, Baltimore, MD, 21224, USA.ORCID http://orcid.org/0000-0003-2809-0901
Blaine BartholomewDepartment of Epigenetics and Molecular Carcinogenesis, Univ. of Texas MD Anderson Cancer Center, Houston, TX, 77230, USA. bbartholomew@mdanderson.org.ORCID http://orcid.org/0000-0003-4014-9750
The University of Texas MD Anderson Cancer Center · USInstitute for Systems Biology · USNational Institute on Aging · US

Funding

Supplement for Google cloud build-outR24GM137786 · NIGMS · UNIV OF ARKANSAS FOR MED SCIS · PI Alan Tackett · 2020 to 2026
$15.4M
Epigenetic mechanisms of mammalian tissue agingZIAAG000679 · NIA · NATIONAL INSTITUTE ON AGING · PI SEN, PAYEL · 2019 to 2025
$6.9M
The interplay between the chromatin remodeler INO80 and histone variant H2A.Z.R01GM108908 · NIGMS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BARTHOLOMEW, BLAINE · 2015 to 2023
$3.7M
The Expedit-Isotopomeric CrossLinking Mass Spectrometry (Expedit-ICLMS) technology for mapping global and dynamic protein-protein interaction networksR01GM136974 · NIGMS · INSTITUTE FOR SYSTEMS BIOLOGY · PI RANISH, JEFFREY A · 2020 to 2023
$2.0M
Regulation of RNA polymerase II pausing and directionality by ATP-dependent chromatin remodelersR01GM131639 · NIGMS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BARTHOLOMEW, BLAINE · 2019 to 2022
$1.8M
Intramural NIH HHS ZIA AG000679NIGMS NIH HHS R01 GM108908NIGMS NIH HHS R01 GM131639NIGMS NIH HHS R01 GM136974NIGMS NIH HHS R24 GM137786
6 · The paper itself

Abstract

The SWI/SNF ATP-dependent chromatin remodeler is a master regulator of the epigenome, controlling pluripotency and differentiation. Towards the C-terminus of the catalytic subunit of SWI/SNF is a motif called the AT-hook that is evolutionary conserved. The AT-hook is present in many chromatin modifiers and generally thought to help anchor them to DNA. We observe however that the AT-hook regulates the intrinsic DNA-stimulated ATPase activity aside from promoting SWI/SNF recruitment to DNA or nucleosomes by increasing the reaction velocity a factor of 13 with no accompanying change in substrate affinity (K

Indexed as

Saccharomyces cerevisiaeTranscription FactorsAdenosine TriphosphateAnimalsCell LineageChromatinDNAMiceNucleosomesAdenosine TriphosphateChromatinDNANucleosomesTranscription Factors

Identifiers

PMID37542049
PMCPMC10403523
OpenAlexW4385580302

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.